Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)

 

Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Reuters Health Features Dr. Kelvin Kwan Lau’s Perspective on Study Examining ALBI Score Versus MELD-Na on Patient Outcomes in a Variety of Surgeries

View All News

Kelvin Kwan N. Lau, MD, Assistant Professor of Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective to Reuters Health on a medical records analysis published in the Journal of the American College of Surgeons that showed the Albumin-Bilirubin (ALBI) score more accurately predicted outcomes in patients undergoing pulmonary, elective colorectal and adrenal operations than the Model for End Stage Liver Disease-sodium (MELD-Na). Dr. Lau is the study’s corresponding author. MD Alert and Medscape picked up the Reuters Health article.